Knight Therapeutics Inc
(GUD.TO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Sales | 1,845 | 1,892 | 1,135 | 1,068 | 343 |
| Cost of Goods | 473 | 296 | 535 | 246 | 52 |
| Gross Profit | 1,372 | 1,596 | 600 | 822 | 291 |
| Operating Expenses | 3,848 | 2,988 | 2,865 | 2,525 | 2,131 |
| Operating Income | -2,476 | -1,392 | -2,265 | -1,703 | -1,840 |
| Other Income | 10,102 | 8,770 | 7,709 | 4,728 | 10,655 |
| Pre-tax Income | 7,626 | 7,378 | 5,444 | 3,025 | 8,815 |
| Income Tax | -313 | 1,680 | 998 | 2,548 | 3,261 |
| Net Income Continuous | 7,939 | 5,698 | 4,446 | 477 | 5,554 |
| Net Income | $7,939 | $5,698 | $4,446 | $477 | $5,554 |
| EPS Basic Total Ops | 0.06 | 0.04 | 0.04 | 0.01 | 0.05 |
| EPS Basic Continuous Ops | 0.06 | 0.04 | 0.04 | 0.01 | 0.05 |
| EPS Diluted Total Ops | 0.06 | 0.04 | 0.04 | 0.01 | 0.05 |
| EPS Diluted Continuous Ops | 0.06 | 0.04 | 0.04 | 0.01 | 0.05 |
| EBITDA(a) | $-2,320 | $-1,292 | $-2,133 | $-1,654 | $8,853 |